奥法木单抗治疗晚期慢性淋巴细胞白血病：英国指定患者同情用药计划的结果 - Suppr

Ofatumumab in advanced stage chronic lymphocytic leukaemia: results of the UK named patient compassionate use programme.

作者信息

Chowdhury Onima, Varghese Abraham, Pattinson Jonathon, Carrington P, Bloor Adrian, Follows George A, Hillmen Peter, Schuh Anna

出版信息

Br J Haematol. 2011 Nov;155(4):519-21. doi: 10.1111/j.1365-2141.2011.08711.x. Epub 2011 May 12.

DOI:10.1111/j.1365-2141.2011.08711.x

PMID:21564074

Abstract

摘要

相似文献

Ofatumumab in advanced stage chronic lymphocytic leukaemia: results of the UK named patient compassionate use programme.奥法木单抗治疗晚期慢性淋巴细胞白血病：英国指定患者同情用药计划的结果

Br J Haematol. 2011 Nov;155(4):519-21. doi: 10.1111/j.1365-2141.2011.08711.x. Epub 2011 May 12.

Assessment of the efficacy of ofatumumab in patients with chronic lymphocytic leukaemia treated in the Department of Haematooncology and Bone Marrow Transplantation of the Medical University in Lublin - Prelimary results.在卢布林医科大学血液肿瘤学与骨髓移植科接受治疗的慢性淋巴细胞白血病患者中奥法木单抗疗效评估——初步结果

Ann Agric Environ Med. 2018 Mar 14;25(1):56-59. doi: 10.5604/12321966.1233571. Epub 2017 Feb 11.

Oral high-dose glucocorticoids and ofatumumab in fludarabine-resistant chronic lymphocytic leukemia.口服大剂量糖皮质激素与奥法木单抗治疗氟达拉滨耐药的慢性淋巴细胞白血病

Leukemia. 2012 May;26(5):1144-5. doi: 10.1038/leu.2011.329. Epub 2011 Nov 8.

[Novel monoclonal antibodies for chronic lymphocytic leukemia - ofatumumab, alemtuzumab].用于慢性淋巴细胞白血病的新型单克隆抗体——奥法木单抗、阿仑单抗

Gan To Kagaku Ryoho. 2015 May;42(5):558-62.

Ofatumumab: chronic lymphocytic leukaemia: a last resort.奥法木单抗：慢性淋巴细胞白血病：最后的治疗手段。

Prescrire Int. 2010 Oct;19(109):201-3.

Ofatumumab for newly diagnosed and relapsed/refractory chronic lymphocytic leukemia.奥法妥木单抗治疗新诊断和复发/难治性慢性淋巴细胞白血病。

Expert Rev Anticancer Ther. 2011 Feb;11(2):151-60. doi: 10.1586/era.10.223.

Efficacy of ofatumumab against rituximab-resistant B-CLL/SLL cells with low CD20 protein expression.奥法木单抗对低CD20蛋白表达的利妥昔单抗耐药B细胞慢性淋巴细胞白血病/小淋巴细胞淋巴瘤细胞的疗效。

Br J Haematol. 2014 Aug;166(3):455-7. doi: 10.1111/bjh.12857. Epub 2014 Mar 27.

Local experience with the novel human anti-CD20 antibody, ofatumumab, as salvage treatment for patients with heavily pretreated chronic lymphocytic leukaemia.新型人抗CD20抗体奥法木单抗用于经大量前期治疗的慢性淋巴细胞白血病患者挽救治疗的本地经验。

Intern Med J. 2012 Jul;42(7):846-8. doi: 10.1111/j.1445-5994.2012.02827.x.

Ofatumumab and its role as immunotherapy in chronic lymphocytic leukemia.奥法木单抗及其在慢性淋巴细胞白血病中作为免疫疗法的作用。

Haematologica. 2015 Apr;100(4):411-4. doi: 10.3324/haematol.2015.124107.

Campath-1H induced pure red cell aplasia in a patient with chronic lymphatic leukaemia.Campath-1H在一名慢性淋巴细胞白血病患者中诱发了纯红细胞再生障碍。

Leuk Res. 2007 Jul;31(7):1025-6. doi: 10.1016/j.leukres.2006.08.012. Epub 2006 Sep 26.

引用本文的文献

Clinical utility and patient considerations in the use of ofatumumab in chronic lymphocytic leukemia.奥法木单抗用于慢性淋巴细胞白血病的临床效用及患者考量

Biologics. 2015 Sep 18;9:75-86. doi: 10.2147/BTT.S60503. eCollection 2015.

Ofatumumab in poor-prognosis chronic lymphocytic leukemia: a phase IV, non-interventional, observational study from the European Research Initiative on Chronic Lymphocytic Leukemia.奥法木单抗治疗预后不良的慢性淋巴细胞白血病：一项来自欧洲慢性淋巴细胞白血病研究倡议的IV期非干预性观察性研究。

Haematologica. 2015 Apr;100(4):511-6. doi: 10.3324/haematol.2014.118158. Epub 2015 Jan 16.

Safety and efficacy of ofatumumab in patients with fludarabine and alemtuzumab refractory chronic lymphocytic leukaemia.奥法妥木单抗治疗氟达拉滨和阿仑单抗难治性慢性淋巴细胞白血病患者的安全性和疗效。

Ther Adv Hematol. 2012 Aug;3(4):199-207. doi: 10.1177/2040620712445329.

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Ofatumumab in advanced stage chronic lymphocytic leukaemia: results of the UK named patient compassionate use programme.

作者信息

出版信息

相似文献

引用本文的文献

文献检索

文件翻译

深度研究

Suppr 超能文献

相似文献

引用本文的文献